WaltherMPfeiferMD

PubMed

• 15 citations
  Role of c-Cbl–Dependent Regulation of Phospholipase Cγ1 Activation in Experimental Choroidal Neovascularization
  Deeba Husain, Rosana D. Meyer, Manisha Mehta, Walther M. Pfeifer, E. Chou, Gregory Navruzbekov, Ednan Ahmed, Nader Rahimi> ;Investigative Ophthalmology & Visual Science. 2010 Dec 1
• 26 citations
  Detection of the Activating JAK2 V617F Mutation in Paraffin-Embedded Trephine Bone Marrow Biopsies of Patients with Chronic Myeloproliferative Diseases
  Thomas Horn, Marcus Kremer, Tobias Dechow, Walther M. Pfeifer, Birgit Geist, Michael Perker, Justus Duyster, Leticia Quintanilla-Martinez, Falko Fend> ;The Journal of Molecular Diagnostics. 2006 Jul 1
• 40 citations
  Fascin expression in CD30-positive cutaneous lymphoproliferative disorders
  Werner Kempf, Edi Levi, Jivko Kamarashev, Heinz Kutzner, Walther M. Pfeifer, Tina Petrogiannis-Haliotis, Günter Burg, Marshall E. Kadin> ;Journal of Cutaneous Pathology. 2002 May 1
• 23 citations
  CD30-activation–mediated growth inhibition of anaplastic large-cell lymphoma cell lines: apoptosis or cell-cycle arrest?
  Edi Levi, Walther M. Pfeifer, Marshall E. Kadin> ;Blood. 2001 Sep 1
• 41 citations
  Pathology of lymphoma progression.
  Hans Konrad Müller-Hermelink, Andreas Zettl, Walther M. Pfeifer, German Ott> ;Histopathology. 2001 Apr 1
• 38 citations
  Distinct effects of CD30 and Fas signaling in cutaneous anaplastic lymphomas: a possible mechanism for disease progression.
  Edi Levi, Zhenxi Wang, Tina Petrogiannis-Haliotis, Walther M. Pfeifer, Werner Kempf, Reed E. Drews, Marshall E. Kadin> ;The Journal of Investigative Dermatology. 2000 Dec 1
• 108 citations
  A Deletion in the Gene for Transforming Growth Factor β Type I Receptor Abolishes Growth Regulation by Transforming Growth Factor β in a Cutaneous T-Cell Lymphoma
  William P. Schiemann, Walther M. Pfeifer, Edi Levi, Marshall E. Kadin, Harvey F. Lodish> ;Blood. 1999 Oct 15
• 45 citations
  A murine xenograft model for human CD30+ anaplastic large cell lymphoma. Successful growth inhibition with an anti-CD30 antibody (HeFi-1).
  Walther M. Pfeifer, Edi Levi, Tina Petrogiannis-Haliotis, Leslie Lehmann, Zhenxi Wang, Marshall E. Kadin> ;The American Journal of Pathology. 1999 Oct 1
• Join now to see all